Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 796.90
+2.10 (0.26%)
Sep 14, 2025, 11:29 AM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 235.51 million as of September 12, 2025. Its market cap has increased by 147.78% in one year.
Market Cap
235.51M
Enterprise Value
189.06M
Revenue
n/a
Ranking
n/a
PE Ratio
213.71
Stock Price
796.90
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 235.51M, a decrease of -80.47%. That is a compound annual growth rate of -35.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2025 | 235.51M | -13.04% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 76.30B |
| Danel (Adir Yeoshua) | 2.90B |
| Kamada | 1.35B |
| SofWave Medical | 979.20M |
| BrainsWay | 973.41M |
| Bait Bakfar | 958.09M |
| Novolog (Pharm-Up 1966) | 719.31M |
| Ilex Medical | 708.32M |